CJC-1295 No DAC 5MG

Description

Unlock advanced endocrine research with CJC-1295 No DAC 5mg from Peptide Therapeutics Institute, a specialized Growth Hormone Releasing Hormone (GHRH) analog designed to stimulate natural, pulsatile growth hormone (GH) secretion. Unlike DAC-modified variants, CJC-1295 No DAC features a shorter half-life that promotes rapid and intermittent GH release patterns closely aligned with the body’s natural hormonal rhythms. This characteristic makes it especially valuable for studies involving controlled GH pulsatility, metabolic regulation, tissue repair, and anabolic signaling. Researchers frequently utilize CJC-1295 No DAC in investigations related to muscle physiology, fat metabolism, recovery pathways, and age-associated hormonal decline. Advance your understanding of endocrine timing and regenerative biology with Peptide Therapeutics Institute’s CJC-1295 No DAC 5mg.

Features

• Stimulates natural, pulsatile growth hormone release
• Supports IGF-1 signaling and anabolic pathway research
• Widely studied in muscle development and fat metabolism models
• Useful in investigations involving tissue repair and recovery biology
• Enhanced structural stability against enzymatic degradation
• Relevant for metabolic, endocrine, and longevity-focused research

Why Choose Peptide Therapeutics Institute’s CJC-1295 No DAC 5mg?

For researchers requiring precise control over growth hormone pulsatility, Peptide Therapeutics Institute’s CJC-1295 No DAC 5mg offers exceptional reliability and research-grade consistency. Its short-acting profile allows investigators to study physiologic GH release patterns without the prolonged exposure associated with DAC-modified analogs. This makes it highly suitable for experiments examining endocrine feedback loops, IGF-1 modulation, body composition, and regenerative signaling. Researchers value its targeted activity and predictable pharmacokinetic behavior in both acute and long-term protocols. With rigorous quality standards and verified peptide purity, Peptide Therapeutics Institute provides a dependable platform for advanced metabolic and hormonal research applications.

Specs

Volume: 5 MG
Purity: Research Grade

Composition:

• CJC-1295 No DAC (Modified GHRH Analog)

Half-life: Approximately 30 Minutes

Molecular Weight: Approximately 3.4 kDa

Structure: Amino Acid Substitutions for Enhanced Stability